| Andrew Reaven, | |
|
1320 West Main Street, Newark, OH 43055-1822 | |
| (220) 564-4218 | |
| (220) 564-4217 |
| Full Name | Andrew Reaven |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 10 Years |
| Location | 1320 West Main Street, Newark, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366862906 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35.129596 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Licking Memorial Hospital | Newark, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Licking Memorial Professional Corporation | 6204740731 | 200 |
News Archive
Clinical trials are underway to test an azithromycin-based combination treatment for pregnant women, "which could tackle some of the leading preventable causes of death for babies in sub-Saharan Africa," according to researchers from the London School of Hygiene & Tropical Medicine (LSHTM), who published a report on Wednesday in the Journal of the American Medical Association.
There is new hope for people with acute myelogenous leukemia (AML), a fast-growing cancer of the blood and bone marrow. Research led by Weill Cornell Medical College and published today in the online edition of the journal Cancer Cell reveals a surprising and unexpected cancer-causing mechanism. The investigators discovered that newly identified mutant enzymes in AML create a chemical poison to cause leukemia. Their findings should prove useful in treating patients by providing a molecular target against which to develop new drugs against one subset of AML as well as other cancers.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
METTLER TOLEDO is proud to announce the launch of its new XPR balance line. Offering both micro and ultra-micro models, XPR offers a welcome combination of usability, accuracy that is critical in industries such as pharma where sample sizes are small and productivity must be maintained.
› Verified 2 days ago
| Entity Name | Licking Memorial Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326072265 PECOS PAC ID: 6204740731 Enrollment ID: O20031203000131 |
News Archive
Clinical trials are underway to test an azithromycin-based combination treatment for pregnant women, "which could tackle some of the leading preventable causes of death for babies in sub-Saharan Africa," according to researchers from the London School of Hygiene & Tropical Medicine (LSHTM), who published a report on Wednesday in the Journal of the American Medical Association.
There is new hope for people with acute myelogenous leukemia (AML), a fast-growing cancer of the blood and bone marrow. Research led by Weill Cornell Medical College and published today in the online edition of the journal Cancer Cell reveals a surprising and unexpected cancer-causing mechanism. The investigators discovered that newly identified mutant enzymes in AML create a chemical poison to cause leukemia. Their findings should prove useful in treating patients by providing a molecular target against which to develop new drugs against one subset of AML as well as other cancers.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
METTLER TOLEDO is proud to announce the launch of its new XPR balance line. Offering both micro and ultra-micro models, XPR offers a welcome combination of usability, accuracy that is critical in industries such as pharma where sample sizes are small and productivity must be maintained.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Reaven, 1320 West Main Street, Newark, OH 43055-1822 Ph: (220) 564-4218 | Andrew Reaven, 1320 West Main Street, Newark, OH 43055-1822 Ph: (220) 564-4218 |
News Archive
Clinical trials are underway to test an azithromycin-based combination treatment for pregnant women, "which could tackle some of the leading preventable causes of death for babies in sub-Saharan Africa," according to researchers from the London School of Hygiene & Tropical Medicine (LSHTM), who published a report on Wednesday in the Journal of the American Medical Association.
There is new hope for people with acute myelogenous leukemia (AML), a fast-growing cancer of the blood and bone marrow. Research led by Weill Cornell Medical College and published today in the online edition of the journal Cancer Cell reveals a surprising and unexpected cancer-causing mechanism. The investigators discovered that newly identified mutant enzymes in AML create a chemical poison to cause leukemia. Their findings should prove useful in treating patients by providing a molecular target against which to develop new drugs against one subset of AML as well as other cancers.
Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.
METTLER TOLEDO is proud to announce the launch of its new XPR balance line. Offering both micro and ultra-micro models, XPR offers a welcome combination of usability, accuracy that is critical in industries such as pharma where sample sizes are small and productivity must be maintained.
› Verified 2 days ago
Dr. Paul Gaston Del Valle, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1320 W Main St, Newark, OH 43055 Phone: 740-348-4318 Fax: 740-348-4217 | |
Michael Isaac Sniderman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1320 West Main Street, Newark, OH 43055 Phone: 220-564-4218 Fax: 220-564-4217 | |
Dr. Ann Govier, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1320 W Main St, Newark, OH 43055 Phone: 220-564-4226 Fax: 220-564-4219 | |
Abhay J. Anand, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1320 West Main Street, Newark, OH 43055 Phone: 220-564-4650 Fax: 220-564-4238 | |
Dr. Shin Kang, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1320 W Main St, Newark, OH 43055 Phone: 740-348-4226 Fax: 740-348-4219 | |
Seung Park, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1320 West Main Street, Newark, OH 43055 Phone: 740-348-4226 Fax: 740-348-4217 | |
Dr. Rr Evans, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1320 W Main St, Newark, OH 43055 Phone: 740-348-4226 Fax: 740-348-4219 |